Biocartis raises €10m

Swiss diagnostics company Biocartis has raised €10m in a Series A funding round.

The round was led by Dutch VC Aescap Venture, and the syndicate comprised of Biovest, KBC Private Equity, both of Belgium, Advent Venture Partners of the UK, and Benaruca of Luxembourg, an existing investor.

Dinko Valerio for Aescap, Rudi Mariën for Biovest, Ruth Devenyns for KBC Private Equity, Raj Parekh for Advent Venture Partners, Peter Verhaeghe for Benaruca and Rudi Pauwels all join the Biocartis board as directors.

The Lausanne-based company is focused on molecular diagnostics and is developing a new micro-technology platform designed to meet the needs of personalized medicine.